Survodutide: A dual GLP-1/glucagon agonist, combining appetite suppression with glucagon's metabolic effects
Inside your body, they work like tiny messengers, passing instructions from one cell to another
KPV (Lysine-Proline-Valine): Tripeptide with anti-inflammatory effects
All orders of goods are sent out within 48 hours of accepting of the order (not including weekends, bank holidays and public holidays)
Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide
B12 is naturally found in animal products like meat, dairy, and eggs, making vegetarians and vegans more susceptible to deficiencies
